血液过滤和净化市场－全球产业规模、份额、趋势、机会和预测（按产品、应用、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球血液过滤和净化市场价值为 38.1 亿美元，预计到 2030 年将达到 58.2 亿美元，预测期内复合年增长率为 7.29%。由于慢性病和血液相关疾病的盛行率不断上升，加上临床环境中人们对先进过滤技术的认识不断提高，该市场正在迅速扩张。血液净化技术对于败血症、慢性肾臟病和各种感染等疾病的管理至关重要，因此对现代医疗保健至关重要。微过滤和纳过滤系统的创新提高了治疗的效率和精确度，而外科手术数量的增加进一步刺激了医院、诊断实验室和诊所的产品需求。此外，更高的医疗保健支出和自动化、人工智慧整合过滤系统的采用有助于简化程序并改善患者的治疗效果。随着越来越多的医疗保健提供者采用先进技术来满足不断变化的医疗需求，血液过滤和净化市场将稳定成长。

关键市场驱动因素

慢性病发生率上升

主要市场挑战

先进过滤装置成本高昂

主要市场趋势

血液过滤治疗的个人化

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球血液过滤与净化市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（过滤套件和试剂、薄膜、过滤器和耗材、样品製备系统、特殊分析和色谱柱）
  • 按应用（传染病诊断、毒理学和免疫诊断、癌症诊断、遗传/分子诊断、其他）
  • 按最终使用者（临床诊断实验室、医院、研究和学术机构等）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美血液过滤与净化市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲血液过滤与净化市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太血液过滤与净化市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲血液过滤与净化市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲血液过滤和净化市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Thermo Fischer Scientific
• MilliporeSigma
• Roche lifescience
• Sigma Aldrich
• Avantor
• Takara Bio
• MP Biomedicals.
• QIAGEN NV
• HiMedia
• Biotage

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Blood Filtration and Purification Market was valued at USD 3.81 Billion in 2024 and is projected to reach USD 5.82 Billion by 2030, growing at a CAGR of 7.29% during the forecast period. This market is expanding rapidly due to the increasing prevalence of chronic and blood-related conditions, coupled with growing awareness of advanced filtration technologies in clinical settings. Blood purification technologies are essential in the management of diseases such as sepsis, chronic kidney disease, and various infections, making them critical to modern healthcare delivery. Innovations in micro- and nano-filtration systems have enhanced the efficiency and precision of treatment, while the rising number of surgical interventions has further fueled product demand across hospitals, diagnostic labs, and clinics. Additionally, higher healthcare spending and the adoption of automated, AI-integrated filtration systems are helping streamline procedures and improve patient outcomes. As more healthcare providers adopt advanced technologies to meet evolving medical needs, the market for blood filtration and purification is poised for steady growth.

Key Market Drivers

Rising Incidence of Chronic Diseases

The growing burden of chronic diseases globally is a key factor driving the Blood Filtration and Purification Market. Conditions such as chronic kidney disease (CKD), diabetes, cardiovascular diseases (CVDs), and autoimmune disorders are increasingly common, resulting in a heightened need for filtration therapies. Over 850 million people suffer from CKD, which often requires dialysis-a treatment dependent on blood purification systems. Similarly, with approximately 830 million people living with diabetes as of 2022, diabetic nephropathy is rising, increasing the demand for blood filtration devices. Cardiovascular diseases, responsible for 17.9 million deaths annually, often lead to fluid overload and toxin buildup, necessitating blood purification treatments. Moreover, autoimmune diseases like rheumatoid arthritis can cause systemic issues, requiring therapies to filter harmful antibodies. With aging populations and growing disease prevalence, the demand for advanced blood purification technologies continues to surge globally.

Key Market Challenges

High Costs of Advanced Filtration Devices

The adoption of advanced blood filtration technologies is limited by the high cost of devices and associated maintenance. These systems often utilize specialized membranes, smart sensors, and integrated AI functionalities, increasing manufacturing and operational expenses. Such high-cost technologies are out of reach for many smaller healthcare providers, especially in developing economies. Additionally, reimbursement gaps in various healthcare systems create financial uncertainty, deterring investment in premium filtration solutions. With limited insurance coverage and minimal government subsidies, the return on investment for hospitals remains a concern. Furthermore, supply chain limitations and high costs of sourcing raw materials hinder affordability. These cost-related barriers not only restrict access but also slow the broader adoption of advanced blood purification across global markets.

Key Market Trends

Personalization of Blood Filtration Treatments

The blood filtration landscape is evolving toward personalized treatment approaches, supported by real-time diagnostics and AI-driven clinical decision-making. Healthcare providers are increasingly customizing filtration therapies based on patient-specific data, including biomarker levels, comorbid conditions, and treatment responses. This trend is especially prevalent in critical care environments where rapid and precise intervention is essential. AI and machine learning tools are now being used to adjust filtration parameters dynamically, enhancing treatment outcomes and minimizing side effects. Biosensor integration and wearable monitoring technologies are also contributing to this shift, enabling continuous patient evaluation and better decision-making. Manufacturers are responding by introducing modular systems and patient-tailored filtration kits. As the healthcare system increasingly emphasizes individualized, outcome-focused care, the trend toward personalized blood purification is expected to become mainstream in both acute and chronic care settings.

Key Market Players

• Thermo Fischer Scientific
• MilliporeSigma
• Roche lifescience
• Sigma Aldrich
• Avantor
• Takara Bio
• MP Biomedicals
• QIAGEN N.V
• HiMedia
• Biotage

Report Scope

In this report, the Global Blood Filtration and Purification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Filtration and Purification Market, By Product:

• Filtration Kits and Reagents
• Membranes, Filters and Consumables
• Sample Preparation Systems
• Specialty Assays and Columns

Blood Filtration and Purification Market, By Application:

• Infectious Disease Diagnostics
• Toxicology and Immunodiagnostics
• Cancer Diagnostics
• Genetic/Molecular Diagnostics
• Others

Blood Filtration and Purification Market, By End User:

• Clinical Diagnostic Labs
• Hospitals
• Research and Academic Institutes
• Others

Blood Filtration and Purification Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Filtration and Purification Market.

Available Customizations

Global Blood Filtration and Purification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Blood Filtration and Purification Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Filtration Kits and Reagents, Membranes, Filters and Consumables, Sample Preparation Systems, Specialty Assays and Columns)
  • 5.2.2. By Application (Infectious Disease Diagnostics, Toxicology and Immunodiagnostics, Cancer Diagnostics, Genetic/Molecular Diagnostics, Others)
  • 5.2.3. By End User (Clinical Diagnostic Labs, Hospitals, Research and Academic Institutes, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Blood Filtration and Purification Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Filtration and Purification Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Mexico Blood Filtration and Purification Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Canada Blood Filtration and Purification Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Blood Filtration and Purification Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Blood Filtration and Purification Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Blood Filtration and Purification Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Filtration and Purification Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Filtration and Purification Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Filtration and Purification Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Blood Filtration and Purification Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Blood Filtration and Purification Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Filtration and Purification Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. South Korea Blood Filtration and Purification Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Japan Blood Filtration and Purification Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Filtration and Purification Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Blood Filtration and Purification Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood Filtration and Purification Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Blood Filtration and Purification Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Blood Filtration and Purification Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Blood Filtration and Purification Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood Filtration and Purification Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Blood Filtration and Purification Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Blood Filtration and Purification Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fischer Scientific
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. MilliporeSigma
• 14.3. Roche lifescience
• 14.4. Sigma Aldrich
• 14.5. Avantor
• 14.6. Takara Bio
• 14.7. MP Biomedicals.
• 14.8. QIAGEN N.V
• 14.9. HiMedia
• 14.10. Biotage

15. Strategic Recommendations

16. About Us & Disclaimer